Present Views on Steroid Therapy in the Nephrotic Syndrome
Steroid therapy of the nephrotic syndrome has been employed by us for fifteen years, which may be divided into the cortisone/ACTH era from 1951 to 1954 and the prednisolone era from 1955 to date.
During the cortisone/ACTH era short-term treatment intended to imitate natural stressful infection was assayed, and a wide range of doses and of lengths of course were tried. Sufficient experience of sudden dramatic amelioration was obtained to indicate great benefit to some patients. In these days of prolonged massive steroid therapy it is salutary to remember two patients rendered asymptomatic and free of proteinuria by five days of cortisone treatment, who remain so fourteen years later. Radical improvement occurred unpredictably but although longer and greater dosage schedules increased the likelihood of such amelioration they introduced hazards due to sodium and water retention and consequent electrolyte upset. One form of treatment derived from the cortisone/ACTH era persists in the highly successful system of intermittent high dosage recommended by Lange et al. (1955) . In 1955 when prednisolone, prednisone and triamcinolone became available, to be augmented by dexamethasone and betamethasone, much more potent and longer dosage schedules began.
When considering treatment of the nephrotic syndrome precise diagnosis is required and the following system is used here:
Definition ofNephrotic Syndrome
The nephrotic syndrome is a clinical syndrome in which gross proteinuria and associated hypoalbuminemia are always present; cedema, ascites and hyperlipxemia are usually present; and "In absentia, read by Dr Arnold Bloom azotemia, systemic hypertension and excessive erythrocyturia are sometimes present.
The nephrotic syndrome has at least forty known causes and probably several unknown causes and it is therefore essential to identify which specific group is being discussed when steroid treatment is considered. The working classification used here is as follows:
Classification
Congenital nephrosis: Various familial, congenital and sometimes hereditary types. Invariably lethal and often beginning in the neonatal period. Many patients die in early infancy, a few survive some years. Well described by Hallman (1956) and Lange et al. (1963) . Seconidary nephrosis: Malarial nephrosis; collagen disease (lupus erythematosus, polyarteritis nodosa, anaphylactoid purpura); toxic nephrosis (drugs, metals, toxins, envenomization); diabetic glomerulosclerosis; post-nephritic nephrosis; amyloidosis; renal vein thrombosis; diverse rarities. Idiopathic nephrosis.
Steroid therapy in our experience is of no value in congenital nephrosis of infancy, may aggravate matters, and probably hastens death. The only form of secondary nephrosis likely to benefit is that associated with disseminated lupus erythematosus. Gilles & Hendrickse (1963) reported poor results in nephrosis associated with quartan malaria.
The use of steroid therapy is therefore virtually confined to what is termed 'idiopathic nephrosis' for lack of a better name. Such cases fall into three clinical groups. In Grade A there is no excess erythrocyturia, systemic hypertension or nitrogen retention. The light microscopy of a renal biopsy is normal and electron microscopy reveals pedicel damage and minimal basement membrane thickening. Proteinuria is largely confined to albuminuria and gammaglobulinuria. It is this group, common in children and rare in adults, which gives the optimal results wben treated with steroids.
In Grade B excessive erythrocyturia is present with or without systemic hypertension and nitrogen retention. On light microscopy the picture varies from normal to basement membrane thickening with hypercellularity. Electron microscopy usually reveals in addition to pedicel damage both epithelial and endothelial thickening. Alphaglobulinuria and betaglobulinuria may be present, giving a mirror image of the plasma proteins.
Grade C presents with macrocytic liematuria and usually with some degree of systemic hypertension and nitrogen retention. This grade, whether in adult or child, responds badly to steroid therapy and may even be aggravated by it. Urinary protein includes considerable but variable proportions of ocand 5-globulins and excess of ceruloplasmin. The histology varies even in this group. On light microscopy thickened basement membrane is usual, hypercellularity, crescentic formation and glomerular destruction often being apparent and the picture may be termed proliferative. TREATMENT Steroid therapy cannot be considered in vacuo but rather as a component of a treatment plan. Our scheme of treatment is:
(a) Dietetic: A low-sodium, low-fluid, high-protein daily diet is given, provided that urea concentrating powers are adequate. The caloric intake of the diet before treatment is estimated and an isocaloric low-carbohydrate diet is given during steroid therapy in an effort to slow the progress of cushingoid obesity resulting from the increased appetite.
(b) Antibiotic: The brine-logged nephrotic with reduced level of plasma y-globulin is very vulnerable to bacterial infections. It is not our practice to give prophylactic antibiotics before or during steroid therapy but rather to treat any infection which arises immediately and vigorously. Prophylactic antibiotics after remission and cessation of steroid therapy, are given only if previous relapse appears to have been provoked by respiratory infection. We have not found infection masked by steroid a very grave problem if clinical supervision is adequate.
Diuretic Therapy
Where the nephrotic syndrome is of the congenital or secondary type and where idiopathic nephrosis presents with hematuria, azotaemia or hypertension, steroid therapy is not used but diuretic therapy is employed instead. Similarly, if steroids 10 have failedor are contraindicated, diuretic therapy is advised. Our usage is to give chlorothiazide (1-4 g/day) and spironolactone-A (25-100 mg/ day) together with potassium chloride (2-4 g/day). This has proved most reliable, both in provoking diuresis and maintaining the child in a relatively cedema-free state. In adults the problems are more difficult and a wide range of diuretics may be tried before effective therapy is selected. Newer diuretics have made little improvement compared to large doses of chlorothiazide and spironolactone-A, since the competent clinician will prevent hypokalaemia by giving adequate supplements. Mercurial diuretics are not advised and intravenous human albumin is ephemeral in effect.
Steroid Treatment
The best cases for treatment are children without excessive erythrocyturia. In this group steroid therapy produces consistently good results and it is rare for dramatic improvement not to occur. An example of such a response is shown in Fig 1. This shows the synchronous loss of proteinuria, diuresis, natruresis and shedding of cedema as judged by weight.
It is quite certain that diuresis (which usually occurs four to twelve days after treatment is Section ofMedicine begun) precedes the rise in plasma proteins. As the rounded contours of crdema recede so does the underlying wasting in the patient become evident. Diuresis occurs in at least 95 % of children with no initial erythrocyturia and loss of cedema is usually complete within a few days. With the gross increase in urinary volume proteinuria is diluted and usually synchronously decreased in absolute amount. Both albuminuria and y-globulinuria decrease to a level where proteinuria is imperceptible to the heat test in the majority of children; to a reduced level of 25-200 mg per day in the minority of children; and remaining above 200 mg per day in perhaps 10 % of children.
These initial results are gratifying but unfortunately they are not usually permanent. In about one-third of cases relapse does not occur, but in 65 % of children return to gross proteinuria occurs on one or more occasions, sometimes after a gap of many months during which the urinary proteins, plasma proteins and plasma lipids have been normal in pattern. Such relapses often follow an upper respiratory infection and may be transient or lead to persisting proteinuria, again producing cedema. Relapses usually respond to second, third or later courses of steroids, as well as initial attacks; but when relapses are frequent, and especially when they occur before steroid treatment has been discontinued, albuminuria and y-globulinuria tend to become persistent and the urine is no longer free from such excess protein between relapses. This problem of relapse is the most vexing in childhood and merits close study. Efforts to prevent such relapses with prophylactic continuous low dosage of steroid, antibiotics and high dosage intermittent steroid treatment have been of no avail. The problem of whether intercurrent respiratory infection provokes anamnestic rises in activity of specific or nonspecific anti-kidney antibodies is unanswered. In cases prone to relapse one is faced with such complications in children as dwarfism and in all age groups with: (1) Cushingoid obesity, moon face and osteoporosis with hirsutism. (2) Hypertension with the risk of convulsions and permanent mental or neurological changes such as hemiplegia.
(3) Glycosuria which may lead to true diabetes mellitus, complicating further steroid therapy. (4) Cutaneous strie due to stretching of the skin which may become so stretched in subsequent relapse that spontaneous leakage of subcutaneous fluid may occur.
All these effects have occurred in our patients but it should be emphasized that they almost always occur only after several courses of steroid therapy unless the cases belong to Grade B or C. Even in the small proportion of cases in adults who have idiopathic nephrosis with no erythrocyturia, systemic hypertension or nitrogen retention the outlook is seldom good. Steroid therapy at best is likely to bring diuresis to no more than two-thirds and loss of significant proteinuria to less than one-quarter. Relapse of proteinuria is common as is return to the salinelogged state of cedema. Furthermore the hazard of hypertension is much greater in the adult patient so treated and permanent return to an asymptomatic state (with proteinuria abolished) is unusual. The use of steroids in producing diuresis in such patients is valuable, but the ultimate effect on prognosis is problematical and will remain so until the results of properly controlled and adequate trials are available. It is our view that prednisolone is the safest of the highly effective steroid preparations available in relation to toxicity and side-effects and details of dosage have been published (Arneil 1963) .
In Grade B patients, in whom some erythrocyturia is noted and light microscopy usually shows at least thickening of basement membrane, the problem is still more vexed; it seems clear that in adults steroid therapy is rarely successful whereas in children the results are unpredictable. Whilst the great majority have diuresis and lose cedema, the minority are freed of proteinuria and many cases relapse frequently. Sophisticated investigation by renal biopsy, differential protein clearance studies in plasma and urine (Cameron & White 1965) and immuno-electrophoresis has not yet resolved the problem of how to choose suitable Grade B cases to treat with steroid and when treatment should be started and when abandoned.
The mode of action of steroids remains a mystery. It has been variously suggested that diuresis results from a depression of aldosterone overproduction and this may indeed be so. It seems odd, however, that proteinuria decreases virtually synchronously. Release of cedema does not decrease proteinuria, as is seen when diuresis is caused by diuretics such as chlorothiazide and spironolactone-A and proteinuria persists ( Fig  2) . Steroid therapy can then abolish the proteinuria. Is it that steroid therapy interrupts a basic antibody production from which this syndrome of proteinuria stems ? Whether this anti-renal antibody be autoimmune in nature or not, this hypothesis is attractive. It might explain why large doses of steroid suppress the nephrotoxic agent and why intercurrent infections re-alight the syndrome. It would support the idea that in children steroid therapy suppresses the signs and leaves a latent process still liable to relapse for as therapy. Diuresis did not eliminate proteinuria but subsequent steroid therapy rapidly did so many years as nephrosis lasted in its fluctuating state before the days of steroid therapy (Arneil 1961) .
It seems that steroid therapy is indicated in adults or children with the idiopathic nephrotic syndrome but no excessive erythrocyturia. It will produce considerable improvement in the great majority of the former and a proportion of the latter. We find that steroids may be used in children with microscopic erythrocyturia with some prospects of improvement but will seldom prove efficacious in adults with this sign.
Steroid therapy is not recommended in nephrotic patients of any age with gross hlematuria, secondarynephrosis or congenital nephrosis.
The outlook is therefore 'good in parts'. The pessimism of former years based on chronically cedematous infection-ridden invalids is no longer true of children and less true of adults. If there is nothing to which the complete answer is known there is yet nothing to which a partial remedy is not to hand. A more pleasant longer life awaits the modern patient afflicted by this disorder than was in store for his like a generation ago, and the younger he is the better. A generally accepted definition of asthma has yet to be found. Professor Scadding (1963) has attempted to get more exact terminology for pulmonary diseases and he defines asthma as follows: 'Asthma is a disease characterized by variable dyspncea due to widespread narrowing of peripheral airways in the lungs, and varying in severity over short periods of time either spontaneously or as a result of treatment.' This describes a disorder of function which simple physiological tests can confirm.
The majority of patients suffering from the disease so defined have no gross pathological changes in the lungs in the early stages: we can subdivide these patients into what we believe to be the main causes, such as (a) allergic or extrinsic asthma when there is evidence that known external allergens provoke symptoms, or (b) infective or intrinsic asthma when respiratory infections do. In these patients the physiological disorder from various stimuli is the primary disability and we might describe this as primary asthma.
If a child develops acute bonchitis with severe asthma for a few days and then recovers completely, the diagnosis would be acute bronchitis with secondary asthma. If, however, recovery was not complete but the child continued to get nocturnal wheezing for some weeks, which ceased when dust and feathers were removed from the bed, the diagnosis would be asthma due to infection plus allergymixed type. Similarly, if a patient with chronic bronchitis and emphysema developed attacks of nocturnal wheezing relieved by bronchodilator drugs, the diagnosis would be chronic bronchitis and emphysema with secondary asthma. Conditions such as polyarteritis nodosa or aspergillus sensitivity may present as asthma but when investigations later reveal the primary disease the diagnosis would be changed to poly-
